VeriMomIst mipa-cocoyl sarcosinate in der Schwangerschaft sicher?
No harmonised reproductive hazard classification (no ECHA Annex VI H360/H361 found) and the Cosmetic Ingredient Review (CIR) safety assessment of sarcosines/sarcosinates concluded these ingredients are 'safe as used' (approved for rinse‑off and limited leave‑on use). No peer‑reviewed evidence of reproductive or developmental toxicity or endocrine disruption specific to cocoyl sarcosinates was identified. Sources: CIR safety assessment (CIR/PubMed) and industry/CosmeticsInfo summary.
Pregnancy-safe products containing mipa-cocoyl sarcosinate
Related ingredients
Frequently asked questions
- Ist mipa-cocoyl sarcosinate in der Schwangerschaft sicher?
- No harmonised reproductive hazard classification (no ECHA Annex VI H360/H361 found) and the Cosmetic Ingredient Review (CIR) safety assessment of sarcosines/sarcosinates concluded these ingredients are 'safe as used' (approved for rinse‑off and limited leave‑on use). No peer‑reviewed evidence of reproductive or developmental toxicity or endocrine disruption specific to cocoyl sarcosinates was identified. Sources: CIR safety assessment (CIR/PubMed) and industry/CosmeticsInfo summary.
- Ist mipa-cocoyl sarcosinate während des Stillens sicher?
- Same rationale as pregnancy: no evidence of reproductive/developmental hazard or mechanism suggesting lactation/transfer concerns; CIR concluded sarcosinates are safe as used. No studies showing placental or milk transfer or effects on neonates were found.
- Ist mipa-cocoyl sarcosinate sicher für Babyhaut?
- No specific developmental/infant toxicity evidence; CIR states sarcosinates are safe in rinse‑off and at limited concentrations in leave‑on use. Dermal absorption data are limited, but sarcosinate surfactants are rinsed and not described as non‑absorbable; per the scoring rules, adult exposure scored 0 and infant exposure increased by +1 because infant skin has higher surface‑area‑to‑weight and an immature barrier. No infant‑specific hazard or mechanism data were found.
- Wie bewertet VeriMom mipa-cocoyl sarcosinate?
- VeriMom bewertet mipa-cocoyl sarcosinate mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu mipa-cocoyl sarcosinate?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu mipa-cocoyl sarcosinate basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.